At the Min Lab, we aim to advance the next generation of engineering tools that enable innovative product designs for precision medicine. We integrate core concepts in chemical engineering, biological sciences, and AI/data science, to arrive at innovative engineering solutions to significant health problems. We focus on developing sophisticated nanomaterials-based platform technologies that enable the rational use of available and/or experimental therapies. Our long-term goal is to utilize these new tools to understand the make-up of diseases and the changes associated with disease progression and therapy. By enabling robust analyses of pharmacodynamic markers, they will also have potential to enable development of new, clinically meaningful biomarkers that can be used to advance drug development.